Vivimed Labs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

16.58

16.58

16.58

16.58

16.58

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

3.91

34.83

78.73

402.69

469.89

Loan funds

Secured loans

374.82

375.47

376.64

356.94

250.80

Unsecured loans

-

-

-

-

-

Total

395.31

426.88

471.96

776.22

737.27

Uses of funds

Fixed assets

Gross block

476.86

471.78

553.89

535.17

507.67

Less : revaluation reserve

38.00

38.00

38.00

38.00

38.00

Less : accumulated depreciation

161.58

145.46

211.03

106.37

91.17

Net block

277.28

288.32

304.86

390.81

378.50

Capital work-in-progress

17.11

20.65

20.67

40.03

58.45

Investments

58.78

58.78

161.14

161.14

161.14

Net current assets

Current assets, loans & advances

247.78

275.72

267.59

441.82

458.75

Less : current liabilities & provisions

205.64

216.59

282.29

257.57

319.57

Total net current assets

42.14

59.13

-14.70

184.24

139.18

Miscellaneous expenses not written

-

-

-

-

-

Total

395.31

426.88

471.96

776.22

737.27

Notes:

Book value of unquoted investments

58.78

58.78

161.14

161.14

161.14

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

182.79

115.69

123.42

215.57

220.66

Number of equity sharesoutstanding (Lacs)

829.14

829.14

829.14

829.14

829.14